Nektar Therapeutics/ US6402681083 /
| 2024-05-10 10:00:00 PM | Chg. +0.1600 | Volume | Bid1:02:26 AM | Ask1:02:26 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.7600USD | +10.00% | 2.36 mill. Turnover: 3.96 mill. |
1.7900Bid Size: 24,900 | 1.8300Ask Size: 100 | 322.6 mill.USD | 0.00% | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -2.86 USD | 14.86% |
| EPS Diluted: | -2.86 USD | 14.86% |
| Revenues per Share: | 0.56 USD | -35.07% |
| Book Value per Share: | 3.71 USD | -38.55% |
| Cash Flow per Share: | -2.25 USD | 28.34% |
| Dividend per Share: | 0.00 USD | - |
| Total | in mill. | |
| Revenues: | 101.90 USD | -33.36% |
| Net Income: | -523.80 USD | 17.87% |
| Operating Cash Flow: | -412.70 USD | - |
| Cash and Cash Equivalents: | 25.20 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 3.17 | 24.30 |
| P/BV ratio: | 0.47 | 3.64 |
| P/CF Ratio: | -0.78 | -6.00 |
| PEG: | -0.04 | - |
| Earnings Yield: | -162.50% | -21.17% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 322.6 mill. USD | 2.48 bill. USD |
| Free Float Market Cap.: | 105.23 mill. USD | 807.79 mill. USD |
| Market Cap. / Employee: | 435,952 USD | 3.35 mill. USD |
| Shares Outstanding: | 183.3 mill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | -437.78% |
| Net Profit Margin: | -514.03% |
| Return on Equity: | -77.09% |
| Return on Assets: | -46.89% |
Financial Strength
| Liquidity I / Cash Ratio: | 29.58% |
| Liquidity II / Quick Ratio: | 55.99% |
| Liquidity III / Current Ratio: | 933.80% |
| Debt / Equity Ratio: | 64.42% |
| Dynam. Debt / Equity Ratio: | -106.06% |
Efficiency
| Employees: | 740 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 137,702.70 USD |
| Net Income / Employee: | -707,837.84 USD |
| Total Assets / Employee: | 1,509,729.73 USD |
| * Fiscal Year End: | 2021-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
